Wyeth Effexor XR Has Increased Risk Of Fatal Outcomes Versus SSRIs
Executive Summary
New labeling for Wyeth's antidepressants Effexor XR (venlafaxine extended-release) and Effexor describes an increased risk of fatal outcomes associated with overdose, according to an Oct. 25 FDA MedWatch alert